Glassman Wealth Services Zai Lab LTD Transaction History

Glassman Wealth Services

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$22.97 - $30.58 $3,307 - $4,403	-144 Reduced 22.15%	506 $13,000
Q3 2023 Nov 13, 2023	BUY	$22.72 - $31.49 $1,272 - $1,763	56 Added 9.43%	650 $15,000
Q2 2023 Aug 08, 2023	BUY	$25.3 - $39.67 $11,840 - $18,565	468 Added 371.43%	594 $16,000
Q1 2023 May 04, 2023	SELL	$30.21 - $48.1 $3,353 - $5,339	-111 Reduced 46.84%	126 $4,000
Q4 2022 Feb 06, 2023	SELL	$22.28 - $38.71 $2,829 - $4,916	-127 Reduced 34.89%	237 $7,000
Q3 2022 Nov 09, 2022	BUY	$34.2 - $51.69 $6,976 - $10,544	204 Added 127.5%	364 $12,000
Q2 2022 Aug 04, 2022	BUY	$23.14 - $49.68 $3,702 - $7,948	160 New	160 $6,000
Q1 2022 Apr 14, 2022	SELL	$27.77 - $64.4 $3,637 - $8,436	-131 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$54.9 - $105.21 $2,250 - $4,313	41 Added 45.56%	131 $8,000
Q3 2021 Nov 10, 2021	BUY	$105.0 - $178.37 $1,050 - $1,783	10 Added 12.5%	90 $9,000
Q2 2021 Aug 04, 2021	SELL	$125.11 - $180.0 $3,503 - $5,040	-28 Reduced 25.93%	80 $14,000
Q4 2020 Feb 04, 2021	BUY	$81.94 - $135.34 $1,229 - $2,030	15 Added 16.13%	108 $15,000
Q3 2020 Nov 09, 2020	BUY	$73.3 - $89.48 $2,712 - $3,310	37 Added 66.07%	93 $8,000
Q2 2020 Aug 06, 2020	BUY	$48.82 - $82.53 $2,733 - $4,621	56 New	56 $5,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.52B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.